Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2020 May 6;27(13):4894–4907. doi: 10.1245/s10434-020-08538-y

TABLE 2.

Univariate and multivariable regression analysis for major complications

Variable Univariate logistic regression Multivariable logistic regression
OR (95% CI) p value OR (95% CI) p value
All histologies
 Age
  < 65 years Reference Reference
  ≥ 65 years 1.66 (1.12–2.46) 0.01 1.72 (1.08–2.75) 0.02
 Gender
  Female Reference
  Male 1.01 (0.73–1.42) 0.94
 Race
  White Reference
  Black 1.44 (0.75–2.79) 0.27
  Other 1.18 (0.69–2.01) 0.54
 BMI
  ≤ 18.5 Reference
  18.5–24.9 1.04 (0.34–3.15) 0.95
  25–29.9 0.91 (0.29–2/76) 0.87
  30–34.9 1.06 (0.34–3.31) 0.93
  35–39.9 1.11 (0.33–3.71) 0.86
  ≥ 40 0.67 (0.17–2.63) 0.56
 Functional status
  Independent Reference
  Partially dependent/totally dependent 2.03 (0.58–7.09) 0.27
 Neoadjuvant chemotherapy
  No neoadjuvant chemotherapy Reference
  Received neoadjuvant chemotherapy 1.18 (0.84–1.66) 0.35
 Histology
  Non-invasive appendiceal Reference Reference
  Invasive appendiceal 1.75 (1.15–2.66) 0.01 2.15 (1.36–3.37) < 0.01
 PCI (median, IQR)
  PCI < 13 Reference Reference
  PCI ≥ 13 2.65 (1.86–3.77) < 0.01 2.13 (1.38–3.29) < 0.01
 CCR
  CCR0 Reference Reference
  CCR1 2.01 (1.43–2.81) < 0.01 1.58 (0.64–3.92) 0.32
Non-invasive histology
 Age
  < 65 years Reference
  ≥ 65 years 1.75 (0.77–3.99) 0.18
 Gender
  Female Reference
  Male 0.58 (0.27–1.22) 0.15
 Race
  White Reference
  Black 1.50 (0.35–6.36) 0.65
  Other 1.80 (0.61–5.36) 0.31
 BMI
  ≤ 18.5 Reference
  18.5–24.9 0.84 (0.35–2.03) 0.49
  25–29.9 0.95 (0.29–3.10) 0.90
  30–34.9 1.69 (0.56–5.19) 0.25
  35–39.9 1.07 (0.19–6.10) 0.95
  ≥ 40 0 (0) 0.83
 Functional status
  Independent Reference
  Partially dependent/totally dependent - -
 Neoadjuvant chemotherapy
  No neoadjuvant chemotherapy Reference
  Received neoadjuvant chemotherapy 0.51 (0.11–2.44) 0.40
 PCI (median, IQR)
  PCI < 13 Reference
  PCI C 13 1.44 (0.67–3.09) 0.35
 CCR
  CCR0 Reference
  CCR1 1.46 (0.71–3.00) 0.30
Invasive histology
 Age
  < 65 years Reference Reference
  ≥ 65 years 1.79 (1.05–3.06) 0.03 2.04 (1.16–3.59) 0.01
 Gender
  Female Reference
  Male 1.10 (0.71–1.71) 0.67
 Race
  White Reference
  Black 1.25 (0.54–2.89) 0.60
  Other 0.49 (0.23–1.05) 0.07
 BMI
  ≤ 18.5 Reference
  18.5–24.9 0.91 (0.19–4.3) 0.91
  25–29.9 0.79 (0.17–3.68) 0.76
  30–34.9 0.94 (0.19–4.54) 0.94
  35–39.9 0.74 (0.14–3.99) 0.73
  ≥ 40 1.67 (0.23–12.22) 0.52
 Functional status
  Independent Reference
  Partially dependent/totally dependent 0.38 (0.04–3.39) 0.38
 Neoadjuvant chemotherapy
  No neoadjuvant chemotherapy Reference
  Received neoadjuvant chemotherapy 1.15 (0.74–1.79) 0.54
 PCI (median, IQR)
  PCI < 13 Reference Reference
  PCI ≥ 13 2.90 (1.93–4.61) < 0.01 2.66 (1.62–4.37) < 0.01
 CCR
  CCR0 Reference Reference
  CCR1 1.94 (1.24–3.04) < 0.01 1.50 (0.91–2.48) 0.11

Bold values indicate statistical significance with a p value of < 0.05